<DOC>
	<DOCNO>NCT02240381</DOCNO>
	<brief_summary>This clinical trial study physiology immunology new-onset post-transplant diabetes mellitus patient undergo allogeneic stem cell transplantation . Oral glucose tolerance testing ( OGTT ) , euglycemic hyperinsulinemic clamp , immune assay use define mechanism associate abnormal glucose homeostasis follow stem cell transplantation . Information clinical trial could use develop standardized screening procedure develop optimal treatment strategy patient develop post-transplant diabetes mellitus .</brief_summary>
	<brief_title>Predicting Development Diabetes Mellitus Patients Undergoing Allogeneic Stem Cell Transplant</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine whether pre-transplant insulin resistance predict development new onset post-transplant diabetes mellitus ( PTDM ) individual without diabetes undergo match related donor ( MRD ) hematopoietic stem cell transplant ( HCT ) . II . To define role circulate tissue-specific Th1 cell development PTDM . III . To characterize phenotype function circulate tissue-specific regulatory T cell ( Tregs ) HCT recipient without PTDM . OUTLINE : Patients undergo OGTT standard 2-step euglycemic hyperinsulinemic clamp procedure prior HCT . Patients undergo repeat OGTT 2-step euglycemic hyperinsulinemic clamp procedure HCT day 90-100 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients undergo MRD allogeneic HCT DONOR : Donors undergo stem cell collection match relate allogeneic stem cell transplant Patients receive allogeneic HCT Recent current history diabetes mellitus , define as:1 ) diabetes therapy within 6 month enrollment , 2 ) fast blood glucose `` preadmit '' ( screen ) visit &gt; = 126 mg/dL Pregnancy breastfeeding Unrelated donor , umbilical cord blood , mismatch , haploidentical transplant Patients receive T cell depletion thymoglobulin part transplant Patients establish , chronic corticosteroid therapy ( &gt; 5 mg /day prednisone prednisone equivalent ) prior transplant ; establish , chronic corticosteroid therapy define daily dose &gt; 5 mg/day prednisone prednisone equivalent least 2 week prior start conditioning/chemotherapy plan continue pretransplant corticosteroid ( &gt; 5 mg/day prednisone prednisone equivalent ) indefinitely transplantation Inability give inform consent Any condition , opinion investigator , might interfere study objective Any reason , opinion investigator , add additional risk patient DONOR : Individuals donate stem cell DONOR : Pregnancy breastfeed DONOR : Inability give inform consent DONOR : Any condition , opinion investigator , might interfere study objective</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>